Advancing the body’s healing capabilities through science-backed medicinal mushroom blends.
Our products are produced for integrative health care as evidence-based, complementary protocols. The mushrooms are grown in a sterile, clean room facility with no soil and are certified organic. Once grown, the medicinal mushrooms are dried and processed into a powdered form, blended and packaged as proprietary blends.
We believe wellness shouldn’t begin after something goes wrong. It should begin today. Every product we offer is designed to complement healthy living by supporting your body’s natural systems with premium functional nutrition.
To achieve our mission we grow hybrid strains of medicinal mushrooms, formulate blends and disseminate these products into the healthcare market infrastructure. We provide education to bridge the gap between the research knowledge of our products and its use in clinical practice for alternative protocols. We provide consumer and health care professionals’ education. Our goal is to spread the use of our products as non-invasive protocols to ultimately become standards of care. The company is expanding capacity to support an ever-increasing demand. The company currently sells product as a food, so no FDA regulations for drugs or nutraceuticals apply other than to register with the FDA. No claims are made that the products cure anything.
We grow proprietary hybrid strains of medicinal mushrooms in a sterile, soil-free clean room facility, certified organic from spore to harvest.
Once harvested, mushrooms are dried and milled into a fine powder, then carefully blended into our proprietary formulas and packaged for freshness.
Finished blends ship directly to customers and partners worldwide, backed by responsive support and clear dosage guidance.
The science behind the cultivation and blending of our medicinal mushrooms has been assembled by the Quantum Health Discoveries Research Institute, and is based on selected case studies, research articles and peer-reviewed literature contained within the National Library of Medicine.
The team researched and compiled scientific data and executed various experiments to determine the most important chemical breakdown and health benefits of the hybrid strains of medicinal mushroom species used in these blends.
The benefits of mushroom compounds on different clinical conditions have attracted the interest of the scientific community in the last decade in order to understand the molecular mechanisms.
This research is complicated by the fact that there are vast amounts of molecules found in the various species and hybrid new strains, making it literally impossible to know all of the mechanisms and pathways leading to favorable outcomes by ingesting these mushroom products.
The journey began in 1972 when the founder was introduced to hybrid strains of medicinal mushrooms, leading to intense research and collaborations; over the next 34 years, research on medicinal mushrooms continued, resulting in the development of over three hundred hybrid strains, some of which showed rapid tumor shrinkage in animals and were introduced in 2006. In 2008, the MyShroom® Immune Health blend was formulated and administered to a cancer patient who was declared tumor-free after 27 days. By 2010, the immune blend was developed and launched, beta tested with other patients, and fully designed, packaged, and introduced as the first product for sale. Between 2013 and 2016, three additional MyShroom® blends were developed and launched — Neural & Cognitive Health, Liver Health, and Blood Sugar Health formulas. In 2016, a compiled dosage observation chart revealed bacteria-killing molecules in mushroom chemistry, showing that the Immune Health blend could cause cell death in both gram-negative and gram-positive bacteria observed from physicians, healthcare practitioners, and customers. From 2015 through 2019, research on MyShroom® chemistry benefits expanded significantly, highlighting applications such as topical use on comatose patients (2015), the ability to cause apoptosis in gram-negative bacteria linked to Lyme disease, pain reduction at high dosages (64 grams) and through topical use, and observed shrinkage of brain lesions in MS patients. By 2020, the brand achieved global distribution and introduced foods and teas designed to deliver the beneficial superior nutrition of MyShroom formulas.
My wife was given 5 days to live. After reaching out for the mushrooms, Ashley immediately started with 13 teaspoons a day. After 6 days we went to a scheduled oncology appointment and to our amazement her oncologist said she was cancer free.
VERIFIED BUYER
I have type 1 diabetes. I started taking the medicinal mushrooms on 2/15/2020 and was able to reduce my insulin intake significantly. This has been life-changing for my daily management.
VERIFIED BUYER
I still have lung cancer, but it has not progressed significantly since the original diagnosis 6 years ago, and I live a relatively normal life thanks to these mushroom blends.
VERIFIED BUYER
Download our informational resources to learn more about MyShroom® products.
